middle.news
Next Science Plans $30M Capital Return After Asset Sale Completion
8:46am on Wednesday 28th of January, 2026 AEDT
•
Healthcare
Read Story
Next Science Plans $30M Capital Return After Asset Sale Completion
8:46am on Wednesday 28th of January, 2026 AEDT
Key Points
Completed asset sale to OSARTIS GmbH for US$50 million
Closing cash balance of US$35.2 million with no debt
Seeking shareholder approval for capital distribution of around A$0.145 per share
CEO and CFO resigned following transition period ending December 2025
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
NXS
OPEN ARTICLE